Hasil Pencarian - P. E. Westerweel

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    S157: BCR::ABL1 DIGITAL PCR IDENTIFIES CHRONIC PHASE CML PATIENTS SUITABLE FOR AN EARLY TKI DISCONTINUATION ATTEMPT: A PATIENT-LEVEL META-ANALYSIS

    S157: BCR::ABL1 DIGITAL PCR IDENTIFIES CHRONIC PHASE CML PATIENTS SUITABLE FOR AN EARLY TKI DISCONTINUATION ATTEMPT: A PATIENT-LEVEL META-ANALYSIS oleh C. Kockerols, S. Dulucq, S. Bernardi, M. Farina, I. Civettini, G. Colafigli, S. Mori, P. Valk, F.-X. Mahon, C. Gambacorti-Passerini, F.-E. Nicolini, M. Breccia, D. Russo, P. E. Westerweel

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia

    Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia oleh P. J. Hengeveld, J. Schilperoord-Vermeulen, M. Y. van der Klift, J. M. N. Dubois, P. M. Kolijn, F. G. Kavelaars, M. Rijken, J. A. Dobber, K. Nasserinejad, S. Kersting, P. E. Westerweel, A. P. Kater, A. W. Langerak, M-D. Levin

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION.

    P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION. oleh C. C. Kockerols, J. J. Janssen, N. M. Blijlevens, S. K. Klein, L. G. van Hussen-Daenen, G. N. van Gorkom, W. M. Smit, P. van Balen, B. J. Biemond, M. J. Cruijsen, M. F. Corsten, P. A. te Boekhorst, H. R. Koene, G. L. van Sluis, J. J. Cornelissen, P. E. Westerweel

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: